Pharmaceutical outsourcing services provider PCI Pharma Services (PCI) has launched a new contained packaging facility at its newly-acquired site near Dublin, Ireland.
The investment is said to be in line with PCI’s strategy to offer improved outsourced pharmaceutical packaging services and to meet the regulatory standards for specialised medicines.
The company manufactures potent molecules at its contained manufacturing facility in Wales, UK.
PCI Pharma Services president and CEO Bill Mitchell said: “The recent acquisition of Millmount Healthcare and further investment in this newest specialised facility adds considerable capacity and capability to our global supply network, enabling us to meet our customers’ ever-changing and evolving needs in many different geographies.
“Moreover, as our fourth acquisition outside the US in the past four years, this expansion further demonstrates our ability to provide our clients with a comprehensive solution to any uncertainty brought upon by ongoing negotiations between the UK and EU as a result of the evolving Brexit situation.”
The launch of the new facility is part of PCI’s initiative to develop high-containment operations services globally.
More than 100 positions are expected to be created over the next five years as the sites.